Liquidia Corp (LQDA) stock
LQDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3075% above fair value
$56.40−0.33 (-0.58%)
Close on Nov 18, 2026Market cap $5.05BP/E 40.6Yield –
Liquidia operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Liquidia's operating income for the twelve months ending Jun 30, 2026 was $168.58M. For fiscal 2025 it was -$51.38M. The highest annual figure on record is -$33.80M in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$51.38M | – |
| FY2024 | Dec 31, 2024 | -$121.29M | – |
| FY2023 | Dec 31, 2023 | -$73.38M | – |
| FY2022 | Dec 31, 2022 | -$38.77M | – |
| FY2021 | Dec 31, 2021 | -$33.80M | – |
| FY2020 | Dec 31, 2020 | -$59.09M | – |
| FY2019 | Dec 31, 2019 | -$46.82M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $85.52M | – |
| Q1 FY2026 | Mar 31, 2026 | $61.50M | – |
| Q4 FY2025 | Dec 31, 2025 | $19.79M | – |
| Q3 FY2025 | Sep 30, 2025 | $1.77M | – |
| Q2 FY2025 | Jun 30, 2025 | -$37.51M | – |
| Q1 FY2025 | Mar 31, 2025 | -$35.43M | – |
| Q4 FY2024 | Dec 31, 2024 | -$36.11M | – |
| Q3 FY2024 | Sep 30, 2024 | -$29.19M | – |
| Q2 FY2024 | Jun 30, 2024 | -$27.20M | – |
| Q1 FY2024 | Mar 31, 2024 | -$28.80M | – |
| Q4 FY2023 | Dec 31, 2023 | -$26.44M | – |
| Q3 FY2023 | Sep 30, 2023 | -$14.89M | – |
| Q2 FY2023 | Jun 30, 2023 | -$22.83M | – |
| Q1 FY2023 | Mar 31, 2023 | -$9.23M | – |
| Q4 FY2022 | Dec 31, 2022 | -$6.50M | – |
| Q3 FY2022 | Sep 30, 2022 | -$8.83M | – |
| Q2 FY2022 | Jun 30, 2022 | -$8.97M | – |
| Q1 FY2022 | Mar 31, 2022 | -$14.47M | – |
| Q4 FY2021 | Dec 31, 2021 | -$11.36M | – |
| Q3 FY2021 | Sep 30, 2021 | -$7.08M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.35M | – |
| Q1 FY2021 | Mar 31, 2021 | -$9.00M | – |
| Q4 FY2020 | Dec 31, 2020 | -$15.91M | – |
| Q3 FY2020 | Sep 30, 2020 | -$14.81M | – |
| Q2 FY2020 | Jun 30, 2020 | -$13.72M | – |
| Q1 FY2020 | Mar 31, 2020 | -$14.65M | – |
See a number that looks wrong?